Pubblicazioni

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers

2022 - ESMO OPEN

Lo Russo, G; Sgambelluri, F; Prelaj, A; Galli, F; Manglaviti, S; Bottiglieri, A; Di Mauro, R M; Ferrara, R; Galli, G; Signorelli, D; De Toma, A; Occhipinti, M; Brambilla, M; Rulli, E; Triulzi, T; Torelli, T; Agnelli, L; Brich, S; Martinetti, A; Dumitrascu, A D; Torri, V; Pruneri, G; Fabbri, A; de Braud, F; Anichini, A; Proto, C; Ganzinelli, M; Mortarini, R; Garassino, M C

Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC

2022 - FRONTIERS IN IMMUNOLOGY

Signorelli, Diego; Ghidotti, Patrizia; Proto, Claudia; Brambilla, Marta; De Toma, Alessandro; Ferrara, Roberto; Galli, Giulia; Ganzinelli, Monica; Lo Russo, Giuseppe; Prelaj, Arsela; Occhipinti, Mario; Viscardi, Giuseppe; Capizzuto, Valentina; Pontis, Francesca; Petraroia, Ilaria; Ferretti, Anna Maria; Colombo, Mario Paolo; Torri, Valter; Sozzi, Gabriella; Garassino, Marina Chiara; Jachetti, Elena; Fortunato, Orazio

Epistemic trust and therapeutic alliance in patient-therapist dyads. How trust affects psychotherapy

2022 - Book of Abstract

Liotti, Marianna; FIORINI BINCOLETTO, Alice; Giovanardi, Guido

The Benedictines in Rome and their influence on the design of the city

2022 - Architecture of the Soul. Diachronic and Multidisciplinary Readings

Turco, Maria Grazia

25P Platinum-based chemotherapy (PCT) addition to first-line PD-1/PD-L1 inhibitors (ICI) prevent hyperprogressive disease (HPD) in non-small cell lung cancer (NSCLC) patients (pts) by reducing circulating immature neutrophils

2022 - IMMUNO-ONCOLOGY TECHNOLOGY

Ferrara, R.; Lo Russo, G.; Ciniselli, C. M.; Bassani, B.; Calareso, G.; Duroni, V.; Di Gregorio, S.; Proto, C.; Prelaj, A.; De Toma, A.; Occhipinti, M.; Brambilla, M.; Manglaviti, S.; Mazzeo, L.; Ganzinelli, M.; De Braud, F. G. M.; Garassino, M. C.; Colombo, M. P.; Verderio, P.; Sangaletti, S.

Trustworthy artificial intelligence models using real-world and circulating genomics data for the prediction of immunotherapy efficacy in non-small cell lung cancer patients

2022 - ANNALS OF ONCOLOGY

Prelaj, A; Bottiglieri, A; Provenzano, L; Spagnoletti, A; Mazzeo, L; Miskovic, V; Ganzinelli, M; Lo Russo, G; Ferrara, R; Proto, C; De Toma, A; Brambilla, M; Occhipinti, M; Manglaviti, S; Beninato, T; Rametta, A; Garassino, Mc; De Braud, Fgm; Trovo, F; Pedrocchi, A

KRAS and LKB1 mutation conferring prognostic and predictive role on liquid biopsy in advanced NSCLC

2022 - ANNALS OF ONCOLOGY

Bottiglieri, A; Provenzano, L; Spagnoletti, A; Mazzeo, L; Ganzinelli, M; Lo Russo, G; Ferrara, R; Proto, C; De Toma, A; Brambilla, M; Occhipinti, M; Manglaviti, S; Beninato, T; Garassino, Mc; Filosa, J; Di Guida, G; De Braud, Fgm; Viscardi, G; Della Corte, Cm; Prelaj, A

Baseline circulating immature neutrophils anticipate hyperprogressive disease (HPD) upon 1st-line PD-1/PD-L1 inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients (pts) and are reduced by platinum-based chemotherapy (PCT) and ICI combinations

2022 - ANNALS OF ONCOLOGY

Ferrara, R; Lo Russo, G; Ciniselli, Cm; Gregorio, S; Calareso, G; Bassani, B; Proto, C; Prelaj, A; De Toma, A; Occhipinti, M; Brambilla, M; Manglaviti, S; Mazzeo, L; Beninato, T; Ganzinelli, M; De Braud, Fgm; Garassino, Mc; Colombo, Mp; Verderio, P; Sangaletti, S

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with novel actionable oncogenic driver alterations

2022 - ANNALS OF ONCOLOGY

Beninato, T; Brambilla, M; Pircher, Cc; Mazzeo, L; Rametta, A; Manglaviti, S; De Toma, A; Galli, G; Prelaj, A; Ferrara, R; Proto, C; Lo Russo, G; Ganzinelli, M; Di Mauro, R; Di Nucci, A; Garassino, Mc; Marchetti, P; De Braud, Fgm; Occhipinti, M

DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients

2022 - ANNALS OF ONCOLOGY

Filetti, M; Occhipinti, M; Cirillo, A; Scirocchi, F; Ugolini, A; Petti, M; Giusti, R; Lombardi, P; Botticelli, A; Lo Russo, G; De Braud, Fgm; Marchetti, P; Nuti, M; Ferretti, E; Rughetti, A; Farina, L

EP07.01-021 Clinical and Biochemical Profiling of Pleural Mesothelioma Patients Treated With Immunotherapy

2022 - JOURNAL OF THORACIC ONCOLOGY

Occhipinti, M.; Tacchetto, A.; Beninato, T.; Pircher, C. C.; Mazzeo, L.; Manglaviti, S.; De Toma, A.; Galli, G.; Prelaj, A.; Ferrara, R.; Proto, C.; Lo Russo, G.; Ganzinelli, M.; Di Nucci, A.; Grande, I.; Rinaldi, A.; Platania, M.; Garassino, M. C.; Marchetti, P.; de Braud, F. M.; Brambilla, M.

EP08.01-006 Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy

2022 - JOURNAL OF THORACIC ONCOLOGY

Prelaj, A.; Galli, E. G.; Pesenti, M.; Viscardi, G.; Bottiglieri, A.; Marinacci, R.; Pedica, B.; Proto, C.; Ferrara, R.; De Toma, A.; Brambilla, M.; Occhipinti, M.; Manglaviti, S.; Galli, G.; Mazzeo, L.; Beninato, T.; Pircher, C. C.; Di Mauro, M. R.; Ganzinelli, M.; Di Nucci, A.; Dumitrascu, A. D.; Di Gregorio, S.; De Braud, F. M. G.; Garassino, M. C.; Restelli, M.; Lo Russo, G.; Trovo', F.; Pedrocchi, A. L. G.

P1.15-02 Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors

2022 - JOURNAL OF THORACIC ONCOLOGY

Proto, C; Chiaruttini, Mv; Prelaj, A; Lo Russo, G; Ferrara, R; Manglaviti, S; De Toma, A; Brambilla, M; Occhipinti, M; Beninato, T; Mazzeo, L; Pircher, C; Dumitrascu, Ad; de Braud, F; Segale, M; Garassino, Mc; Sozzi, G; Porcu, L; Rulli, E; Boeri, M

MA10.07 Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)

2022 - JOURNAL OF THORACIC ONCOLOGY

Proto, C.; Galli, G.; Manglaviti, S.; Lo Russo, G.; Ganzinelli, M.; Galli, F.; Musca, M.; Rulli, E.; Di Mauro, R.; Mella, G.; Lucarelli, A.; Paggio, A.; Valleggi, S.; Ballatore, Z.; Maso, A. Dal; Perrino, M.; Chella, A.; Sbrana, A.; Prelaj, A.; Ferrara, R.; Occhipinti, M.; Brambilla, M.; De Toma, A.; Mazzeo, L.; Beninato, T.; Pircher, C.; de Braud, F.; Pasello, G.; Petrini, I.; Berardi, R.; Garassino, M.; Zucali, P.

Prefazione

2022 - Verso un'antropologia della sorditÃ . Luoghi, pratiche linguistiche, narrazioni

Zuccala', Amir; Fontana, Sabina

Recensione a Douglas Olson, Aristophanesâ Clouds: a commentary, Michigan Classical Commentaries, Ann Arbor: University of Michigan Press, 2021

2022 - EXEMPLARIA CLASSICA

Lentini, Giuseppe

La promozione della cultura architettonica. Mostre, congressi, conferenze, concorsi

2022 - BOLLETTINO DEL CENTRO DI STUDI PER LA STORIA DELL'ARCHITETTURA

DI MARCO, Fabrizio

Diet and foraging ecology of the Hoopoe Upupa epops in a Mediterranean area of Central Italy

2022 - AVOCETTA

Annessi, Matteo; DE BIASE, Alessio; Montemaggiori, Alessandro

Domiziano: memoria âdannataâ o rispettata? Una riflessione sulla documentazione epigrafica di Roma

2022 - Studies in Roman Imperial History for Anthony R. Birley

Gregori, G. L.; Romano, A.

Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance

2022 - DIABETES RESEARCH AND CLINICAL PRACTICE

Succurro, Elena; Marini, Maria Adelaide; Riccio, Alessia; Fiorentino, Teresa Vanessa; Perticone, Maria; Sciacqua, Angela; Andreozzi, Francesco; Sesti, Giorgio

Investigating the Cybersecurity of Smart Grids Based on Cyber-Physical Twin Approach

2022 - Proceedings of 2022 IEEE International Conference on Communications, Control, and Computing Technologies for Smart Grids (SmartGridComm)

Sen, Omer; Schmidtke, Florian; Carere, Federico; Santori, Francesca; Ulbig, Andreas; Monti, Antonello

Vulnerability factors and neuropsychiatric disorders: What could be learned from individual variability in cognitive functions

2022 - FRONTIERS IN PSYCHOLOGY

Daprati, E; Nico, D

Ricerc@Sapienza

Pubblicazioni

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers

Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC

Epistemic trust and therapeutic alliance in patient-therapist dyads. How trust affects psychotherapy

The Benedictines in Rome and their influence on the design of the city

25P Platinum-based chemotherapy (PCT) addition to first-line PD-1/PD-L1 inhibitors (ICI) prevent hyperprogressive disease (HPD) in non-small cell lung cancer (NSCLC) patients (pts) by reducing circulating immature neutrophils

Trustworthy artificial intelligence models using real-world and circulating genomics data for the prediction of immunotherapy efficacy in non-small cell lung cancer patients

KRAS and LKB1 mutation conferring prognostic and predictive role on liquid biopsy in advanced NSCLC

Baseline circulating immature neutrophils anticipate hyperprogressive disease (HPD) upon 1st-line PD-1/PD-L1 inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients (pts) and are reduced by platinum-based chemotherapy (PCT) and ICI combinations

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with novel actionable oncogenic driver alterations

DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients

EP07.01-021 Clinical and Biochemical Profiling of Pleural Mesothelioma Patients Treated With Immunotherapy

EP08.01-006 Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy

P1.15-02 Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors

MA10.07 Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)

Prefazione

Recensione a Douglas Olson, Aristophanesâ Clouds: a commentary, Michigan Classical Commentaries, Ann Arbor: University of Michigan Press, 2021

La promozione della cultura architettonica. Mostre, congressi, conferenze, concorsi

Diet and foraging ecology of the Hoopoe Upupa epops in a Mediterranean area of Central Italy

Domiziano: memoria âdannataâ o rispettata? Una riflessione sulla documentazione epigrafica di Roma

Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance

Investigating the Cybersecurity of Smart Grids Based on Cyber-Physical Twin Approach

Vulnerability factors and neuropsychiatric disorders: What could be learned from individual variability in cognitive functions

Prognostic value of the Tpeak-Tend interval for in-hospital subacute ventricular arrhythmias in tako-tsubo syndrome

NO TAXATION WITHOUT REPRESENTATION. LA FORMAZIONE STORICA DEL PRINCIPIO DEL CONSENSO ALLA TASSAZIONE

Gli obblighi di monitoraggio fiscale del trust estero: problematiche operative e prospettive evolutive